false
Catalog
2023 World Conference on Lung Cancer (Posters)
EP17.06. COVID-19 Long-Lasting Effect on Lung Canc ...
EP17.06. COVID-19 Long-Lasting Effect on Lung Cancer Diagnoses in Italy: Update of the Real-World Multicenter COVID-DELAY Study - PDF(Slides)
Back to course
Pdf Summary
A study conducted in Italy examined the long-lasting effects of the COVID-19 pandemic on lung cancer diagnoses. The study analyzed clinical records of newly diagnosed lung cancer patients referred to 18 Oncology Departments between March and December of 2019, 2020, 2021, and 2022. The findings show a significant decrease in lung cancer diagnoses in 2020 compared to 2019, and this drop persisted in 2021 and 2022. However, there was a rebound in diagnoses in 2021 and 2022 compared to 2020. The study also found that more lung cancer cases were diagnosed at stage IV in 2020, but this trend tended to settle in 2021 and 2022. The diagnostic and therapeutic pathway for lung cancer patients took longer in 2021 and 2022 compared to both 2019 and 2020. The participation in clinical trials consistently decreased from 2019 to 2022. The study also evaluated the progression-free survival of lung cancer patients and found that it was significantly shorter in 2021 and 2022 compared to 2019. These findings indicate a worsening drop in lung cancer diagnoses during the COVID-19 pandemic and highlight the long-term impact on cancer care outcomes and healthcare costs. Understanding these effects is crucial in managing cancer patients within the context of the pandemic. Further research is needed to delve deeper into the implications of COVID-19 on cancer care.
Asset Subtitle
Giulia Mentrasti
Meta Tag
Speaker
Giulia Mentrasti
Topic
Global Health, Health Services & Health Economics: COVID 19
Keywords
Italy
COVID-19 pandemic
lung cancer diagnoses
clinical records
Oncology Departments
diagnostic trends
stage IV diagnoses
diagnostic and therapeutic pathway
clinical trials participation
progression-free survival
×
Please select your language
1
English